Conservest Capital Advisors, Inc. Iridex Corp Transaction History
Conservest Capital Advisors, Inc.
- $1 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding IRIX
# of Institutions
23Shares Held
2.82MCall Options Held
0Put Options Held
2K-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$1.26 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA595KShares$749,4310.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny379KShares$477,7410.0% of portfolio
-
Amh Equity LTD190KShares$239,4000.23% of portfolio
-
Geode Capital Management, LLC Boston, MA132KShares$166,0260.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $20.1M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...